This treatment stabilized the p53 protein and increased the steady-state levels of p53 in the colon cancer cells; the observed increase was the highest for the parent SW48 cells that were used for the ChIP assay (Figure 2E). This evidence concerns the gene TP53 and colonic neoplasm.